Patent 12122776 was granted and assigned to Gilead Sciences on October, 2024 by the United States Patent and Trademark Office.
The present disclosure relates generally to certain tetracyclic compounds, pharmaceutical compositions comprising said compounds, and methods of making said compounds and pharmaceutical compositions. The compounds of the disclosure are useful in treating or preventing human immunodeficiency virus (HIV) infection.